UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

__________________

FORM 10-Q

__________________

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~December 3031, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File Number: 1-39093

BellRing Brands, Inc.

(Exact name of registrant as specified in its charter)


Delaware						87-3296749
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

~~2503~~1 SN Brentwood Blvd., ~~Hanley~~Suite ~~Road~~1550

St. Louis, Missouri ~~63144~~63105

(Address of principal executive offices) (Zip Code)

(314) 644-~~7600~~7652

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value per share	BRBR	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Common Stock, $0.01 par value per share – 117,269,523 shares as of January 27, 2026

Table of Contents

BELLRING BRANDS, INC.

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	1
	Condensed Consolidated Statements of Operations (Unaudited)	1
	Condensed Consolidated Statements of Comprehensive Income (Unaudited)	2
	Condensed Consolidated Balance Sheets (Unaudited)	3
	Condensed Consolidated Statements of Cash Flows (Unaudited)	4
	Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited)	5
	Notes to Condensed Consolidated Financial Statements (Unaudited)	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1415
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	1819
Item 4.	Controls and Procedures	1920
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	2021
Item 1A.	Risk Factors	2021
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2021
Item 5.	Other Information	2021
Item 6.	Exhibits	2223
	SIGNATURES	2324

Table of Contents

PART I. FINANCIAL INFORMATION.

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED).

BELLRING BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in millions, except per share data)

Three Months EndedJune 30,

Nine Months EndedJune 30,

Three Months EndedDecember 31,

~~2025~~

~~2024~~

2025

2024

Net Sales

~~547.5~~

~~515.4~~

~~1,668~~537.43

~~1,440~~532.49

Cost of goods sold

~~353.9~~

~~325.5~~

~~1,085~~376.45

~~938~~333.23

Gross Profit

~~193.6~~

~~189.9~~

~~583~~160.08

~~502~~199.26

Selling, general and administrative expenses

~~144.5~~

~~74.0~~

~~315~~78.10

~~195~~80.91

Amortization of intangible assets

~~4.3~~

124.73

304.72

Operating Profit

~~44.8~~

~~111.6~~

~~255~~78.25

~~275~~115.63

Interest expense, net

~~18.4~~

~~14.4~~

4920.30

4314.84

Earnings before Income Taxes

~~26.4~~

~~97.2~~

~~205~~58.95

~~231~~100.89

Income tax expense

~~5.4~~

~~23.5~~

4914.38

5724.0

Net Earnings

~~21.0~~

~~73.7~~

~~156~~43.67

~~174~~76.89

Earnings per Common Share:

Basic

~~0.17~~

~~0.57~~

10.2237

10.3460

Diluted

~~0.16~~

~~0.56~~

10.2136

10.3259

Weighted-Average Common Shares Outstanding:

Basic

~~126.6~~

~~130.0~~

~~127~~119.93

~~130~~128.79

Diluted

~~128.0~~

~~132.1~~

~~129~~119.79

~~132~~131.71

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

Table of Contents

BELLRING BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(in millions)

	Three Months EndedJune 30,				Nine Months EndedJune 30,
			Three Months EndedDecember 31,
	~~2025~~		~~2024~~		2025		2024
Net Earnings	$	~~21.0~~	$	~~73.7~~	$	~~156~~43.67	$	~~174~~76.89
Unrealized foreign currency translation adjustments	~~1.8~~		~~(0.1)~~		~~1.1~~—		0(1.34)
Other Comprehensive Income (Loss)	1.8		(0.1)		1.1		0.3
Other Comprehensive Loss					—		(1.4)
Total Comprehensive Income	$	~~22.8~~	$	~~73.6~~	$	~~157~~43.7	$	~~175~~75.15

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

Table of Contents

BELLRING BRANDS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions)

	June 30,2025		September 30,2024
	December 31,2025		September 30,2025
ASSETS
Current Assets
Cash and cash equivalents	$	4364.71	$	7071.8
Restricted cash	1112.29		017.3
Receivables, net	~~243~~246.90		~~220~~223.4
Inventories	~~415~~435.62		~~286~~330.14
Prepaid expenses and other current assets	2528.01		1522.16
Total Current Assets	~~739~~786.43		~~592~~665.75
Property, net	1226.5		919.20
Goodwill	65.9		65.9
Intangible assets, net	~~129~~120.27		~~141~~125.80
Deferred income taxes	3327.06		1232.94
Other assets	1333.73		1433.52
Total Assets	$	~~993~~1,060.73	$	~~837~~941.0
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Accounts payable	$	~~126~~178.06	$	~~121~~119.05
Other current liabilities	~~164~~173.4		82163.73
Total Current Liabilities	~~290~~352.40		~~203~~282.78
Long-term debt	1,~~009~~184.06		~~833.~~1,084.3
Deferred income taxes	0.4		0.4
Other liabilities	334.80		527.74
Total Liabilities	1,~~303~~571.60		1,~~042~~394.9
Stockholders’ Deficit
Common stock	1.4		1.4
Additional paid-in capital	4346.20		3748.37
Retained earnings	~~213~~316.03		56272.46
Accumulated other comprehensive loss	(01.90)		(21.0)
Treasury stock, at cost	(~~566~~873.64)		(~~299~~775.06)
Total Stockholders’ Deficit	(~~309~~510.97)		(~~205~~453.9)
Total Liabilities and Stockholders’ Deficit	$	~~993~~1,060.73	$	~~837~~941.0

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

Table of Contents

BELLRING BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

	Nine Months EndedJune 30,
	Three Months EndedDecember 31,
	2025		2024
Cash Flows from Operating Activities
Net earnings	$	~~156~~43.67	$	~~174~~76.89
Adjustments to reconcile net earnings to net cash provided by operating activities:
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Depreciation and amortization	134.89		314.86
Non-cash stock-based compensation expense	165.94		156.51
Deferred income taxes	~~(21~~4.0)7		~~(10.~~2).8
Other, net	~~0.1~~—		1.70
Other changes in operating assets and liabilities:
Increase in receivables, net	(2122.85)		(621.40)
Increase in inventories	(~~128~~104.37)		(4364.42)
(Increase) decrease in prepaid expenses and other current assets	(9.8)		0.2
Increase in prepaid expenses and other current assets	(5.4)		(15.6)
Decrease (increase) in other assets	1.3		(3.4)
Decrease in other assets	0.3		0.9
Increase in accounts payable and other current liabilities	83.7		54.9
Increase (decrease) in accounts payable and other current liabilities	69.9		(8.5)
Net Cash Provided by Operating Activities	91.5		159.5
Increase in non-current liabilities	0.6		—
Net Cash (Used in) Provided by Operating Activities	(3.1)		3.0
Cash Flows from Investing Activities
Additions to property	(34.72)		(01.63)
Net Cash Used in Investing Activities	(34.72)		(01.63)
Cash Flows from Financing Activities
Proceeds from issuance of long-term debt	~~360~~180.0		—35.0
Repayments of long-term debt	(~~185~~80.0)		(2535.0)
Purchases of treasury stock	(~~267~~96.9)		(~~106~~11.18)
Tax withholding payments related to stock compensation plans	(118.54)		(311.54)
Net Cash Used in Financing Activities	(~~104~~5.43)		(~~134~~23.62)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	0.45		~~(0.1)~~—
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash	(16.2)		24.2
Net Decrease in Cash, Cash Equivalents and Restricted Cash	(12.1)		(21.5)
Cash, Cash Equivalents and Restricted Cash, Beginning of Year	7189.1		4871.41
Cash, Cash Equivalents and Restricted Cash, End of Period	$	5477.90	$	7249.6

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

Table of Contents

BELLRING BRANDS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (Unaudited)

(in millions)

As of and for theThree Months EndedJune 30,

As of and for the Nine Months Ended June 30,

As of and for the Three Months Ended December 31,

~~2025~~

~~2024~~

2025

2024

Common Stock

Beginning and end of period

~~1.4~~

1.4

Additional Paid-in Capital

Beginning of period

~~37.9~~

~~26.1~~

3748.37

1937.3

Activity under stock and deferred compensation plans

~~0.1~~

—

(118.01)

(311.23)

Non-cash stock-based compensation expense

~~5.2~~

~~5.5~~

165.94

156.51

End of period

~~43.2~~

~~31.6~~

4346.20

3132.61

Retained Earnings (Accumulated Deficit)

Retained Earnings

Beginning of period

~~192.0~~

~~(89.0)~~

56272.46

~~(190~~56.1)4

Net earnings

~~21.0~~

~~73.7~~

~~156~~43.67

~~174~~76.89

End of period

~~213.0~~

~~(15.3)~~

~~213~~316.03

~~(15~~133.3)

Accumulated Other Comprehensive Loss

Beginning of period

~~(2.7)~~

(21.0)

(32.10)

Foreign currency translation adjustments

~~1.8~~

~~(0.1)~~

~~1.1~~—

0(1.34)

End of period

~~(0.9)~~

~~(2.8)~~

(01.90)

(23.84)

Treasury Stock

Beginning of period

~~(482.7)~~

~~(183.5)~~

(~~299~~775.06)

(~~151~~299.0)

Purchases of treasury stock

~~(83.9)~~

~~(74.6)~~

(~~267~~97.68)

(~~107~~11.10)

End of period

~~(566.6)~~

~~(258.1)~~

(~~566~~873.64)

(~~258~~310.10)

Total Stockholders’ Deficit

~~(309.9)~~

~~(243.2)~~

(~~309~~510.97)

(~~243~~146.26)

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).

Table of Contents

BELLRING BRANDS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in millions, except per share information and where indicated otherwise)

NOTE 1 — BACKGROUND AND BASIS OF PRESENTATION

BellRing Brands, Inc. is a consumer products holding company operating in the global ~~convenient~~proactive ~~nutrition~~wellness category and is a provider of ready-to-drink (“RTD”) protein shakes and powders. The Company’s ~~has a single operating and reportable segment, with its~~ principal products ~~being~~are protein-based consumer goods. ~~The~~and ~~Company’s~~its primary brands are Premier Protein and Dymatize.

Unless otherwise stated or the context otherwise indicates, all references in these financial statements and notes to “BellRing,” the “Company,” “us,” “our” or “we” mean BellRing Brands, Inc. and its subsidiaries.

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), under the rules and regulations of the United States (the “U.S.”) Securities and Exchange Commission (the “SEC”), and on a basis substantially consistent with the audited consolidated financial statements of the Company as of and for the fiscal year ended September 30, ~~2024~~2025. These unaudited condensed consolidated financial statements should be read in conjunction with such audited consolidated financial statements, which are included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, ~~2024~~2025, filed with the SEC on November 1918, ~~2024~~2025.

These unaudited condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments and accruals) that management considers necessary for a fair statement of the Company’s results of operations, comprehensive income, financial condition, cash flows and stockholders’ equity for the interim periods presented. Interim results are not necessarily indicative of the results for any other interim period or for the entire fiscal year. ~~Certain reclassifications have been made to previously reported financial information to conform to the current year presentation.~~

NOTE 2 — RECENTLY ISSUED ACCOUNTING STANDARDS

The Company has considered all new accounting pronouncements and has concluded there are no new pronouncements (other than the ones described below) that had or will have a material impact on the Company’s results of operations, comprehensive income, financial condition, cash flows, stockholders’ equity or related disclosures based on current information.

In ~~November~~September ~~2024~~2025, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) ~~2024~~2025-0306, “~~Income~~Intangibles ~~Statement~~—~~Reporting~~ ~~Comprehensive~~Goodwill ~~Income~~and Other —~~Expense~~ ~~Disaggregation~~Internal-Use ~~Disclosures~~Software (Subtopic ~~220~~350-40): ~~Disaggregation~~Targeted ofImprovements ~~Income~~to ~~Statement~~the ~~Expenses~~Accounting for Internal-Use Software.” This ASU is effective for fiscal years beginning after December 15, ~~2026~~2027 (i.e., the Company’s annual financial statements for the year ended September 30, ~~2028~~2029) ~~and for interim periods within fiscal years beginning after December 15~~, ~~2027 (i.e., the Company’s interim financial statements for the three months ended December 31, 2028),~~ with early adoption permitted. This ASU can be adopted either (i) prospectively, to(ii) ~~financial~~using ~~statements~~a ~~issued~~modified ~~for~~transition ~~reporting~~approach ~~periods after the effective date of this ASU~~ or (iiiii) retrospectively ~~to any or all prior periods presented in the financial statements~~. The Company is currently evaluating the impact of this standard.

In ~~December~~November ~~2023~~2024, the FASB issued ASU ~~2023~~2024-0903, “Income ~~Taxes~~Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (~~Topic~~Subtopic ~~740~~220-40): ~~Improvements~~Disaggregation toof Income ~~Tax~~Statement ~~Disclosures~~Expenses.” This ASU is effective for fiscal years beginning after December 15, ~~2024~~2026 (i.e., the Company’s annual financial statements for the year ended September 30, ~~2026~~2028) and for interim periods within fiscal years beginning after December 15, 2027 (i.e., the Company’s interim financial statements for the three months ended December 31, 2028), with early adoption permitted. This ASU ~~should~~can be adopted either (i) prospectively; ~~however,~~to ~~retrospective~~financial ~~adoption~~statements isissued ~~permitted~~for reporting periods after the effective date of this ASU or (ii) retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact of this standard.

In ~~November~~December 2023, the FASB issued ASU 2023-0709, “~~Segment~~Income ~~Reporting~~Taxes (Topic ~~280~~740): Improvements to ~~Reportable~~Income ~~Segment~~Tax Disclosures,.” ~~which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses.~~ This ASU is effective for fiscal years beginning after December 15, ~~2023~~2024 (i.e., the Company’s annual financial statements for the year ended September 30, ~~2025~~2026), ~~and~~with ~~for~~early ~~interim~~adoption ~~periods~~permitted. ~~within~~This ~~fiscal~~ASU ~~years~~should ~~beginning~~be ~~after~~adopted ~~December~~prospectively; 15however, ~~2024~~retrospective ~~(i.e.,~~adoption ~~the~~is ~~Company’s~~permitted. ~~interim~~Upon ~~financial~~adoption, ~~statements for~~ the ~~three~~impact ~~months~~of ~~ended December 31, 2025), with early adoption permitted. This~~ ASU ~~requires~~2023-09 ~~retrospective~~will ~~adoption.~~be ~~The~~limited ~~Company~~to iscertain ~~currently~~notes ~~evaluating~~to the ~~impact~~Company’s ofannual ~~this~~consolidated ~~standard~~financial statements.

Table of Contents

NOTE 3 — REVENUE

The following table presents net sales by product.

Three Months EndedJune 30,

Nine Months EndedJune 30,

Three Months EndedDecember 31,

~~2025~~

~~2024~~

2025

2024

Shakes

~~438.3~~

~~412.2~~

~~1,365~~432.34

~~1,160~~439.15

Powders

~~92.4~~

~~90.1~~

~~261~~92.61

~~243~~81.92

Other

~~16.8~~

~~13.1~~

4112.58

3612.42

Net Sales

~~547.5~~

~~515.4~~

~~1,668~~537.43

~~1,440~~532.49

NOTE 4 — RELATED PARTY TRANSACTIONS

Transactions between the Company and Post Holdings, Inc. (“Post”) are considered related party transactions as certain of the Company’s directors serve as officers and/or directors of Post.

MSA Fees and Royalties

The Company uses certain functions and services performed by Post under a master services agreement (the “MSA”). These functions and services include finance, internal audit, treasury, information technology support, insurance and tax matters, the use of office and/or data center space, tax compliance services and, prior to January 2025, payroll processing services. MSA fees were $0.7 and $20.39 during the three ~~and nine~~ months ended ~~June~~December 3031, 2025, ~~respectively,~~ and ~~$0.8 and $2.5 during the three and nine months ended June 30,~~ 2024, respectively. MSA fees were reported in “Selling, general and administrative expenses” in the Condensed Consolidated Statements of Operations.

The Company licenses certain intellectual property to and from Post and its subsidiaries based upon prices governed by agreements between the Company and Post and its subsidiaries, consistent with prices of similar arm's-length transactions. During both the three ~~and nine~~ months ended ~~June~~December 3031, 2025 and 2024, royalties paid to and received from Post and its subsidiaries were immaterial.

Co-Packing Agreement

Premier Nutrition Company, LLC (“Premier Nutrition”), a subsidiary of the Company, has a co-packing agreement with Comet Processing, Inc. (“Comet”), a wholly-owned subsidiary of Post (the “Co-Packing Agreement”). Under the Co-Packing Agreement, Premier Nutrition procures certain packaging materials for Comet that Comet utilizes in the production of RTD shakes for Premier Nutrition. ~~Comet began manufacturing RTD shakes in December 2023.~~ The Company purchased $1719.14 and $446.23 of RTD shakes from Comet during the three ~~and nine~~ months ended ~~June~~December 3031, 2025, ~~respectively,~~ and ~~$4.3 and $6.2 of RTD shakes from Comet during the three and nine months ended June 30,~~ 2024, respectively.

As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the Company had current payables with Post of $47.0 and $13.57, respectively, ~~primarily~~ related to RTD shake purchases and MSA fees, which were included in “Accounts payable” on the Condensed Consolidated Balance Sheets. Current receivables with Post at both ~~June~~December 3031, 2025 and September 30, ~~2024~~2025 were immaterial.

NOTE 5 — EARNINGS PER SHARE

Basic earnings per share is based on the average number of shares of common stock outstanding during each period. Diluted earnings per share is based on the average number of shares of common stock used for the basic earnings per share calculation, adjusted for the dilutive effect of stock options and restricted stock units using the “treasury stock” method.

Table of Contents

The following table presents the computation of basic and diluted earnings per share.

	Three Months EndedJune 30,				Nine Months EndedJune 30,
			Three Months EndedDecember 31,
	~~2025~~		~~2024~~		2025		2024
Net earnings	$	~~21.0~~	$	~~73.7~~	$	~~156~~43.67	$	~~174~~76.89
Weighted-average shares for basic earnings per share	~~126.6~~		~~130.0~~		~~127~~119.93		~~130~~128.79
Effect of dilutive securities:
Stock options	~~0.2~~		~~0.2~~		0.21		0.2
Restricted stock units	~~0.2~~		~~0.3~~		0.32		0.3
Performance-based restricted stock units	~~1.0~~		~~1.6~~		10.3		1.57
Weighted-average shares for diluted earnings per share	~~128.0~~		~~132.1~~		~~129~~119.79		~~132~~131.71
Basic earnings per common share	$	~~0.17~~	$	~~0.57~~	$	10.2237	$	10.3460
Diluted earnings per common share	$	~~0.16~~	$	~~0.56~~	$	10.2136	$	10.3259

~~There~~The ~~were~~following notable ~~anti-dilutive~~presents the securities that have been excluded from the calculation of weighted-average shares for diluted earnings per share ~~during~~as ~~the~~they ~~three~~were ~~or nine months ended June 30, 2025 or 2024~~anti-dilutive.

	June 30,2025		September 30,2024
	Three Months EndedDecember 31,
Raw materials and supplies	$	90.7	$	57.3
shares in millions	2025		2024
Work in process	—		—
Restricted stock units	0.1		—
Finished products	324.9		228.8
Performance-based restricted stock units	0.3		—
Inventories	$	415.6	$	286.1

NOTE 6 — INVENTORIES

	June 30,2025		September 30,2024
	December 31,2025		September 30,2025
Property, at cost	$	26.1	$	21.4
Raw materials and supplies	$	92.7	$	88.3
Accumulated depreciation	(13.6)		(12.2)
Work in process	0.1		0.1
Property, net	$	12.5	$	9.2
Finished products	342.4		242.0
Inventories	$	435.2	$	330.4

NOTE 7 — PROPERTY, NET


	December 31, 2025		September 30, 2025
Property, at cost	$	41.3	$	33.2
Accumulated depreciation	(14.8)		(14.2)
Property, net	$	26.5	$	19.0

NOTE 8 — GOODWILL

The components of “Goodwill” on the Condensed Consolidated Balance Sheets at both ~~June~~December 3031, 2025 and September 30, ~~2024~~2025 are presented in the following table.




Goodwill, gross	$	180.7
Accumulated impairment losses	(114.8)
Goodwill	$	65.9

Table of Contents

NOTE 9 — INTANGIBLE ASSETS, NET

	June 30, 2025						September 30, 2024
	December 31, 2025						September 30, 2025
	CarryingAmount		AccumulatedAmortization		NetAmount		CarryingAmount		AccumulatedAmortization		NetAmount
Customer relationships	$	160.8	$	(~~101~~105.26)	$	5955.62	$	160.78	$	(94103.64)	$	6657.14
Trademarks and brands	164.45		(9499.80)		6965.65		164.45		(8896.79)		7567.76
Other intangible assets	3.1		(3.1)		—		3.1		(3.1)		—
Intangible assets, net	$	328.34	$	(~~199~~207.17)	$	~~129~~120.27	$	328.24	$	(~~186~~203.4)	$	~~141~~125.80

In fiscal 2023, the Company approved a plan to discontinue the PowerBar business in North America. In connection with the discontinuance, the Company updated the useful lives of the customer relationships and trademark associated with the PowerBar business in North America to reflect the remaining period in which the Company expected to sell existing PowerBar product inventory in North America. Accelerated amortization of $17.4 was recorded during the nine months ended June 30, 2024 resulting from the updated useful lives of the customer relationships and trademark associated with the PowerBar business in North America, which were fully amortized and written off in fiscal 2024.

NOTE 10 — DERIVATIVE FINANCIAL INSTRUMENTS

In the ordinary course of business, the Company is exposed to commodity price risks relating to the purchases of raw materials and supplies. The Company utilizes derivative instruments, such as futures and option contracts, to manage certain of these exposures by hedging when it is practical to do so. The Company does not hold or issue financial instruments for speculative or trading purposes.

At ~~June~~December 3031, 2025, the Company’s derivative instruments, none of which were designated as hedging instruments under Accounting Standards Codification (“ASC”) Topic 815, “Derivatives and Hedging,” consisted of commodity futures ~~and option~~ contracts which relate to inputs that generally will be utilized within the next twelve months. The notional amounts of the commodity contracts were $~~173~~97.76 and $53136.56 at ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, respectively.

The following table presents the balance sheet location and fair value of the Company’s commodity contracts. The Company does not offset derivative assets and liabilities within the Condensed Consolidated Balance Sheets.

June 30,2025

September 30,2024

December 31,2025

September 30,2025

Prepaid expenses and other current assets

0.12

~~2.7~~—

Other current liabilities

$9.4

~~4.9~~

$12.6

~~0.1~~

The Company recognized a loss (gain) ~~loss~~ on derivatives of $(1.~~0) and $~~8.6 ~~during the three~~ and ~~nine months ended June 30, 2025, respectively, and~~ $(0.18) ~~and $6.0~~ during the three ~~and nine~~ months ended ~~June~~December 3031, 2025 and 2024, respectively, which were recorded in “Cost of goods sold” in the Condensed Consolidated Statements of Operations.

At ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the Company had cash deposits which served as pledged collateral for certain of its commodity contracts of $1112.29 and $017.3, respectively, which were classified as “Restricted cash” on the Condensed Consolidated Balance Sheets.

NOTE 11 — FAIR VALUE MEASUREMENTS

The Company utilizes the income approach to measure fair value for its commodity derivatives using Level 2 inputs. The income approach uses pricing models that rely on market observable inputs such as yield curves and forward prices. Refer to Note 10 for the classification of changes in fair value of derivative assets and liabilities measured at fair value on a recurring basis within the Condensed Consolidated Statements of Operations.

The Company’s financial assets and liabilities also include cash, cash equivalents and restricted cash, receivables and accounts payable for which the carrying value approximates fair value due to their short maturities (less than 12 months). The Company does not record its long-term debt at fair value on the Condensed Consolidated Balance Sheets. The fair value of any outstanding borrowings under the Revolving Credit Facility (as defined in Note 12) approximated its carrying value. Based on market rates, the fair value (Level 2) of the Company’s debt, excluding any outstanding borrowings under the Revolving Credit Facility ~~(as defined in Note 12)~~, was $~~876~~869.2 and $~~880~~869.60 as of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, respectively.

Certain assets and liabilities, including property, goodwill and other intangible assets, are measured at fair value on a non-recurring basis using Level 3 inputs.

Table of Contents

NOTE 12 — LONG-TERM DEBT

The following table presents the components of “Long-term debt” on the Condensed Consolidated Balance Sheets.

	June 30,2025		September 30,2024
	December 31,2025		September 30,2025
7.00% senior notes maturing in March 2030	$	840.0	$	840.0
Revolving Credit Facility	~~175~~350.0		—250.0
Total principal amount of debt	$	1,~~015~~190.0	$	~~840~~1,090.0
Less: Debt issuance costs, net	65.04		65.97
Long-term debt	$	1,~~009~~184.06	$	~~833.~~1,084.3

On March 10, 2022, the Company entered into a credit agreement (as amended, the “Credit Agreement”), which ~~provides~~provided for a revolving credit facility in an aggregate principal amount of $250.0 (the “Revolving Credit Facility”), with commitments made available to the Company in U.S. Dollars, Euros and United Kingdom (“U.K.”) Pounds Sterling. Letters of credit are available under the Credit Agreement in an aggregate amount of up to $20.0. ~~Any outstanding amounts under the Credit Agreement must be repaid on or before March 10, 2027.~~

~~Borrowings~~On ~~under~~August ~~the~~22, ~~Revolving Credit Facility bear interest at an annual rate equal to: (i) in the case of loans denominated in U.S. Dollars~~2025, at the Company’s ~~option,~~entered ~~the~~into ~~base rate (as defined in the Credit Agreement) plus~~ a ~~margin~~First ~~which~~Amendment ~~ranges from 2.00%~~ to ~~2.75% depending on~~ the ~~Company’s secured net leverage ratio (as defined in the~~ Credit Agreement), ~~or the adjusted term SOFR rate~~ (~~as defined in~~ the ~~Credit Agreement~~“Amendment”) ~~for~~by ~~the~~and ~~applicable~~among ~~interest period plus a margin which ranges from 3.00% to 3.75% depending on~~ the Company~~’s secured net leverage ratio; (ii) in the case of loans denominated in Euros~~, ~~the adjusted Eurodollar rate (~~as ~~defined~~borrower, incertain ~~the~~of ~~Credit Agreement) for~~ the ~~applicable interest period plus a margin which ranges from 3.00% to 3.75% depending on the~~ Company’s ~~secured~~subsidiaries, ~~net~~as ~~leverage~~guarantors, ~~ratio;~~JPMorgan ~~and~~Chase ~~(iii)~~Bank, ~~in the case of loans denominated in U~~N.KA. ~~Pounds~~as ~~Sterling,~~administrative ~~the~~agent ~~adjusted~~and ~~daily~~each ~~simple~~lender ~~RFR~~ (as defined in the Credit Agreement) ~~plus a margin which ranges from 3~~.~~00%~~ to 3.75% depending on the Company’s secured net leverage ratio. Facility fees on the daily unused amount of commitments under the Revolving Credit Facility accrue at rates ranging from 0.25% to 0.375% per annum, depending on the Company’s secured net leverage ratio.

~~During~~The ~~the~~Amendment ~~nine~~amended ~~months~~the ~~ended~~Company’s ~~June~~Credit 30Agreement to, ~~2025~~among other matters, (i) increase the ~~Company~~aggregate ~~borrowed~~principal ~~$360.0~~amount ~~and~~available ~~repaid~~under the Revolving Credit Facility to $~~185~~500.0, ~~under~~(ii) extend the maturity date of the Revolving Credit Facility. ~~During~~to ~~the~~August ~~nine~~22, ~~months~~2030, ~~ended~~provided ~~June~~that 30if on December 14, ~~2024~~2029, the Company’s ~~had~~7.00% noSenior ~~borrowings~~Notes have not been redeemed in full in cash or refinanced and ~~repaid~~replaced ~~$25.0~~in ~~under~~full ~~the~~with ~~Revolving~~notes ~~Credit~~and/or ~~Facility.~~loans Asmaturing ofat ~~June~~least ~~30,~~91 ~~2025,~~days ~~the~~after ~~interest~~August ~~rate~~22, on2030, then the ~~utilized~~maturity ~~portion~~date of the Revolving Credit Facility ~~was~~will ~~9.50%~~be December 14, 2029, (iii) reduce the ~~available~~interest ~~borrowing~~rate ~~capacity~~on borrowings under the Revolving Credit Facility ~~was~~(as ~~$75.0~~discussed below) and ~~there~~(iv) ~~were~~broaden nocertain ~~outstanding~~exceptions ~~letters~~to ofcovenants ~~credit.~~contained Asin ofthe ~~September~~Credit ~~30,~~Agreement ~~2024,~~that ~~there~~would ~~were~~otherwise norestrict ~~amounts~~certain ~~outstanding~~activities ~~under~~by the ~~Revolving Credit Facility~~Company, ~~the~~such ~~available~~as ~~borrowing~~repurchases ~~capacity~~by ~~under~~ the ~~Revolving~~Company ~~Credit~~of ~~Facility~~its ~~was~~common ~~$250~~stock.0 ~~and there were no outstanding letters of credit.~~

~~Under~~Following the ~~terms~~Amendment, ofborrowings under the Revolving Credit ~~Agreement~~Facility bear interest at an annual rate equal to: (i) in the case of loans denominated in U.S. Dollars, at the Company’s isoption, ~~required~~the tobase ~~maintain~~rate (as defined in the Credit Agreement) plus a ~~total~~margin which will range from 1.00% to 1.75% depending on the Company’s secured net leverage ratio (as defined in the Credit Agreement), ~~not~~or tothe ~~exceed~~term 6SOFR rate (as defined in the Credit Agreement) for the applicable interest period plus a margin which will range from 2.00:1% to 2.0075% depending on the Company’s secured net leverage ratio; (ii) in the case of loans denominated in Euros, ~~measured~~the adjusted Eurodollar rate (as ofdefined in the ~~last~~Credit ~~day~~Agreement) offor ~~each~~the ~~fiscal~~applicable ~~quarter~~interest period plus a margin which will range from 2.00% ~~The~~to ~~total~~2.75% depending on the Company’s secured net leverage ratio; and (iii) in the case of loans denominated in U.K. Pounds Sterling, the daily simple RFR (as defined in the Credit Agreement) plus a margin which will range from 2.00% to 2.75% depending on the Company’s ~~did~~secured ~~not~~net ~~exceed~~leverage ~~this~~ratio. ~~threshold~~Facility asfees on the daily unused amount of ~~June~~commitments 30under the Revolving Credit Facility initially will accrue at rates ranging from 0.25% to 0.35% per annum, ~~2025~~depending on the Company’s secured net leverage ratio.

Prior to the Amendment, borrowings under the Revolving Credit Facility bore interest at an annual rate equal to: (i) in the case of loans denominated in U.S. Dollars, at the Company’s option, the base rate (as defined in the Credit Agreement) plus a margin which ranged from 2.00% to 2.75% depending on the Company’s secured net leverage ratio (as defined in the Credit Agreement), or the adjusted term SOFR rate (as defined in the Credit Agreement) for the applicable interest period plus a margin which ranged from 3.00% to 3.75% depending on the Company’s secured net leverage ratio; (ii) in the case of loans denominated in Euros, the adjusted Eurodollar rate (as defined in the Credit Agreement) for the applicable interest period plus a margin which ranged from 3.00% to 3.75% depending on the Company’s secured net leverage ratio; and (iii) in the case of loans denominated in U.K. Pounds Sterling, the adjusted daily simple RFR (as defined in the Credit Agreement) plus a margin which ranged from 3.00% to 3.75% depending on the Company’s secured net leverage ratio. Facility fees on the daily unused amount of commitments under the Revolving Credit Facility accrued at rates ranging from 0.25% to 0.375% per annum, depending on the Company’s secured net leverage ratio.

During the three months ended December 31, 2025 and 2024, the Company borrowed $180.0 and $35.0 under the Revolving Credit Facility, respectively, and repaid $80.0 and $35.0 under the Revolving Credit Facility, respectively. As of December 31, 2025, the interest rate on the utilized portion of the Revolving Credit Facility was 5.78% and the available borrowing capacity under the Revolving Credit Facility was $147.6, including $2.4 in outstanding letters of credit. As of September 30, 2025, the interest rate on the utilized portion of the Revolving Credit Facility was 6.14% and the available borrowing capacity under the Revolving Credit Facility was $247.6, including $2.4 in outstanding letters of credit.

Table of Contents

Under the terms of the Credit Agreement, the Company is required to maintain a total net leverage ratio (as defined in the Credit Agreement) not to exceed 6.00:1.00, measured as of the last day of each fiscal quarter. The total net leverage ratio of the Company did not exceed this threshold as of December 31, 2025.

The Credit Agreement provides for potential incremental revolving and term facilities at the Company’s request and at the discretion of the lenders or other persons providing such incremental facilities, in each case on terms to be determined, and also permits the Company to incur other secured or unsecured debt, in all cases subject to conditions and limitations as specified in the Credit Agreement.

Furthermore, the Credit Agreement provides for customary events of default. Upon the occurrence and during the continuance of an event of default, the maturity of the loans under the Credit Agreement may accelerate and the administrative agent and lenders under the Credit Agreement may exercise other rights and remedies available at law or under the loan documents, including with respect to the collateral securing, and guarantees of, the Company’s obligations under the Credit Agreement.

The Company’s obligations under the Credit Agreement are unconditionally guaranteed by its existing and subsequently acquired or organized direct and indirect subsidiaries (other than immaterial subsidiaries, certain excluded subsidiaries and subsidiaries the Company designates as unrestricted subsidiaries) and are secured by security interests in substantially all of the Company’s assets and the assets of its subsidiary guarantors, but excluding, in each case, real property.

Table of Contents

NOTE 13 — COMMITMENTS AND CONTINGENCIES

Legal Proceedings

Joint Juice Litigation

In March 2013, a complaint was filed on behalf of a putative, nationwide class of consumers against Premier Nutrition in the U.S. District Court for the Northern District of California seeking monetary damages and injunctive relief. The case asserted that some of Premier Nutrition’s advertising claims regarding its Joint Juice line of glucosamine and chondroitin dietary supplement beverages, which it discontinued in the first quarter of fiscal 2023, were false and misleading. In April 2016, the district court certified a California-only class of consumers in this lawsuit (this lawsuit is hereinafter referred to as the “California Federal Class Lawsuit”). In April 2018, the district court dismissed the California Federal Class Lawsuit with prejudice. This dismissal was upheld on appeal by the U.S. Court of Appeals for the Ninth Circuit in 2020, and plaintiff’s petition for an en banc rehearing by the Ninth Circuit was denied.

In September 2020, the same lead counsel re-filed the California Federal Class Lawsuit against Premier Nutrition in the California Superior Court for the County of Alameda, alleging identical claims and seeking restitution and injunctive relief on behalf of the same putative class of California consumers as the California Federal Class Lawsuit. In March 2023, the Alameda Superior Court granted in part and denied in part Premier Nutrition’s motion for judgment based on res judicata, and in May 2023, the Court reaffirmed its ruling. In July 2023, Premier Nutrition filed a petition for writ of mandamus in the California Court of Appeal, which writ was denied in March 2024. In November 2023, the Court certified the case as a class action. Trial is currently stayed pending the resolution of the appeal in the action on behalf of New York consumers described in more detail below (the “New York Case”). In January 2025, the plaintiff filed a motion for the application of issue preclusion arising from certain rulings in the New York Case. On May 14, 2025, the court entered an order holding that issue preclusion will apply on certain issues.

In 2016 and 2017, the lead plaintiff’s counsel in the California Federal Class Lawsuit filed ten additional class action complaints in the U.S. District Court for the Northern District of California on behalf of putative classes of consumers under the laws of Connecticut, Florida, Illinois, New Jersey, New Mexico, New York, Maryland, Massachusetts, Michigan and Pennsylvania (the “Related Federal Actions”). These complaints contain factual allegations similar to the California Federal Class Lawsuit, also seeking monetary damages and injunctive relief. The action on behalf of New Jersey consumers was voluntarily dismissed. Trial in the New York Case was held beginning in May 2022, and the jury delivered its verdict in favor of plaintiff in June 2022. In August 2022, the Court entered a judgment in that case in favor of plaintiff in the amount of $12.9, which includes statutory damages and prejudgment interest, and in August 2023, the Court entered a judgment awarding plaintiff $7.9 in attorneys’ fees and costs. In October 2022, each plaintiff and Premier Nutrition filed Notices of Appeal to the Ninth Circuit on the damages award and in December 2023 Premier Nutrition filed its Notice of Appeal to the Ninth Circuit on the attorneys’ fees award. In August 2024, the Court of Appeals issued an opinion on the damages award affirming the trial court’s decision on liability, vacating and remanding to the trial court for further consideration its decision on calculated damages and reversing the trial court’s award of prejudgment interest to plaintiff. Premier Nutrition’s subsequent petition for en banc rehearing with the Ninth Circuit Court of Appeals was denied in October 2024. On January 25, 2025, the Ninth Circuit affirmed the trial court’s attorneys’ fees award. On February 3, 2025, the trial court entered an order awarding $0.9 in attorneys’ fees and costs. On March 10, 2025, the trial court entered an order again limiting statutory damages to $8.3 under the due process clause. Each plaintiff and Premier Nutrition filed Notices of Appeal to the Ninth Circuit on the damages award. On March 13, 2025, Premier Nutrition filed a certiorari petition with the United States Supreme Court seeking review of the Ninth Circuit’s merits decision.

In February 2025, the court set a trial date for February 2026 in the Related Federal Action on behalf of the class of consumers in Illinois (the “Illinois Case”). Plaintiff filed a motion to apply issue preclusion from certain rulings in the New York Case to the Illinois Case. On May 2, 2025, the trial court entered an order holding that issue preclusion will apply in the Illinois Case on the issues of deceptiveness, materiality, the measure of damages, and the First Amendment, but not on the issues of causation, intent, or punitive damages. The seven other Related Federal Actions remain pending, and the court has certified individual state classes in each of those cases (except New Mexico).

In January 2019, the same lead counsel filed an additional class action complaint against Premier Nutrition in California Superior Court for the County of Alameda, alleging claims similar to the above actions and seeking monetary damages and injunctive relief on behalf of a putative class of California consumers, beginning after the California Federal Class Lawsuit class period (the “California State Case”). In July 2020, the court issued an order certifying a statewide class. Premier Nutrition moved for summary judgment in July 2023, which motion remains pending. In January 2025, the plaintiff filed a motion for the application of issue preclusion arising from certain rulings in the New York Case decision. On May 14, 2025, the court entered an order holding that issue preclusion will apply on certain issues.

On June 25, 2025, the parties reached a class-wide settlement in principle related to the Joint Juice Litigation, which includes the California Federal Class Lawsuit, all of the Related Federal Actions and the California State Case through a court-

Table of Contents

~~ordered~~process ~~settlement conference, which settlement in principle is subject to judicial approval~~clause. OnEach ~~June~~plaintiff ~~26,~~and ~~2025,~~Premier ~~the~~Nutrition ~~parties~~ filed aNotices ~~joint~~of ~~motion~~Appeal ~~with the United States Supreme Court~~ to ~~hold~~ the ~~certiorari~~Ninth ~~petition~~Circuit inon the ~~New~~damages ~~York Case in abeyance pending approval of the class settlement~~award. On ~~July~~March 213, 2025, ~~the~~Premier ~~parties~~Nutrition filed a ~~joint~~certiorari ~~motion~~petition with the ~~Ninth~~United ~~Circuit~~States toSupreme ~~hold~~Court ~~the~~seeking ~~appeal~~review ~~in the New York Case in abeyance pending approval~~ of the ~~class~~Ninth ~~settlement.~~Circuit’s ~~The~~merits ~~parties will now seek judicial approval of the settlement~~decision.

~~During~~In February 2025, the ~~three~~court ~~and~~set ~~nine~~a ~~months~~trial ~~ended~~date ~~June~~for ~~30,~~February ~~2025,~~2026 in the ~~Company~~Related ~~expensed~~Federal ~~$68.1~~Action ~~and~~on ~~$69.0,~~behalf ~~respectively,~~of ~~related~~the toclass ~~the~~of ~~legal~~consumers ~~matter~~in ~~and~~Illinois ~~plaintiff~~(the ~~legal~~“Illinois ~~fees~~Case”). inPlaintiff ~~connection~~filed ~~with~~a ~~the~~motion ~~Joint~~to ~~Juice~~apply ~~litigation,~~issue ~~which~~preclusion ~~was~~from ~~included~~certain rulings in ~~“Selling,~~the ~~general~~New ~~and~~York ~~administrative~~Case ~~expenses”~~to on the ~~Condensed~~Illinois ~~Consolidated~~Case. ~~Statements~~On ofMay ~~Operations.~~2, ~~Other~~2025, ~~than~~the ~~legal~~trial ~~fees,~~court noentered ~~expense~~an ~~related~~order toholding ~~this~~that ~~litigation~~issue ~~was~~preclusion ~~incurred~~will ~~during~~apply in the ~~three~~Illinois orCase ~~nine~~on ~~months~~the ~~ended~~issues ~~June~~of 30deceptiveness, ~~2024.~~materiality, Atthe ~~June~~measure 30of damages, ~~2025~~ and ~~September~~the ~~30,~~First ~~2024~~Amendment, ~~the~~but ~~Company~~not ~~had~~on anthe ~~estimated~~issues ~~liability~~ of ~~$90.0 and $21.0~~causation, ~~respectively~~intent, ~~related~~or topunitive ~~these~~damages. ~~matters~~The ~~that~~court ~~was~~certified ~~included~~individual instate ~~“Other~~classes ~~current~~in ~~liabilities”~~each onof the ~~Condensed~~seven ~~Consolidated~~other ~~Balance~~Related ~~Sheets~~Federal Actions (except New Mexico).

~~Protein~~In ~~Products~~January 2019, the same lead counsel filed an additional class action complaint against Premier Nutrition in California Superior Court for the County of Alameda, alleging claims similar to the above actions and seeking monetary damages and injunctive relief on behalf of a putative class of California consumers, beginning after the California Federal Class ~~Litigation~~Lawsuit class period (the “California State Case”). In July 2020, the court issued an order certifying a statewide class. Premier Nutrition moved for summary judgment in July 2023, which motion remains pending. In January 2025, the plaintiff filed a motion for the application of issue preclusion arising from certain rulings in the New York Case decision. On May 14, 2025, the court entered an order holding that issue preclusion will apply on certain issues.

InOn June ~~2023~~25, a2025, ~~complaint~~the ~~was~~parties ~~filed~~reached ~~on behalf of~~ a ~~putative,~~class-wide ~~nationwide~~settlement ~~class~~in ofprinciple ~~consumers~~related ~~against~~to the ~~Company~~Joint ~~and~~Juice ~~Premier~~Litigation, ~~Nutrition~~which inincludes the ~~U.S.~~California ~~District~~Federal ~~Court~~Class ~~for~~Lawsuit, ~~the~~all ~~Northern District~~ of ~~California.~~the ~~The~~Related ~~complaint~~Federal ~~alleges~~Actions ~~that Premier Nutrition engages in fraud~~ and ~~false~~the ~~advertising~~California ~~(via~~State ~~alleged~~Case ~~affirmative~~through ~~representations~~a ~~and~~court-ordered ~~omissions)~~settlement ~~regarding~~conference, ~~its~~which ~~RTD~~settlement ~~protein~~in ~~shakes~~principle ~~and~~is ~~protein~~subject ~~powders~~to byjudicial ~~marketing~~approval. ~~the~~On ~~products~~June as26, ~~good~~2025, ~~sources of nutrition and protein when~~ the ~~products~~parties ~~contain~~filed ~~(or have~~ a ~~material~~joint ~~risk~~motion ofwith ~~containing)~~the ~~high~~United ~~levels~~States ofSupreme ~~undisclosed~~Court ~~lead (this lawsuit is hereinafter referred~~ to ashold the ~~“Protein~~certiorari ~~Products~~petition ~~Class~~in ~~Lawsuit”).~~the ~~Plaintiffs~~New ~~seek~~York ~~monetary~~Case ~~remedies~~in ~~for~~abeyance ~~economic~~pending ~~injury~~approval ~~(products~~of ~~are~~the ~~allegedly~~class ~~worth~~settlement. ~~less~~On ~~than~~July ~~what~~2, ~~was paid for them)~~2025, asthe ~~well~~parties asfiled ~~injunctive~~a ~~relief.~~joint ~~The~~motion ~~Protein~~with ~~Products~~the ~~Class~~Ninth ~~Lawsuit~~Circuit ~~alleges~~to ~~that~~hold ~~high~~the ~~levels~~appeal ofin ~~lead~~the ~~pose~~New ~~serious~~York ~~safety~~Case ~~risks,~~in ~~but~~abeyance ~~does~~pending ~~not~~approval ~~allege~~of ~~that~~the ~~any plaintiff or putative~~ class ~~member suffered personal injuries and does not seek any remedies for personal injuries~~settlement.

~~The~~On ~~Company~~October ~~and~~17, ~~Premier~~2025, ~~Nutrition~~the ~~filed~~parties executed a ~~motion~~Stipulation toof ~~dismiss~~Settlement ~~this case~~ in ~~August~~the ~~2023,~~New ~~which~~York ~~motion~~Case ~~was~~(the ~~granted~~“New inYork ~~part~~Settlement”). ~~and~~On ~~denied~~October in20, ~~part.~~2025, ~~Plaintiffs~~Plaintiff filed an ~~amended~~unopposed ~~complaint~~motion infor ~~July~~preliminary ~~2024~~approval of the New York Settlement. On December 5, ~~and~~2025, inthe ~~August~~court ~~2024~~granted preliminary approval of the ~~Company~~New ~~and~~York ~~Premier~~Settlement ~~Nutrition~~and ~~filed~~scheduled a ~~motion~~final approval hearing for April 30, 2026. Pursuant to ~~dismiss~~the terms of the ~~amended~~New ~~complaint~~York Settlement, ~~which~~the ~~motion~~Company ~~was~~paid ~~granted~~$2.0 ininto ~~part~~a ~~and~~settlement ~~denied~~fund into ~~part~~resolve inthe ~~May~~New ~~2025~~York Case. OnIf ~~June~~the ~~24,~~settlement ~~2025~~receives final approval and becomes effective, the ~~parties~~Company ~~reached~~will apay an additional of $17.2 into that settlement ~~related~~fund. toThe ~~the~~New ~~Protein~~York ~~Products~~Settlement ~~Class~~does ~~Lawsuit~~not ~~for~~constitute an ~~immaterial~~admission ~~amount~~of ~~and~~liability onor ~~July~~wrongdoing ~~18,~~by ~~2025,~~the ~~plaintiffs~~Company ~~voluntarily~~or ~~dismissed~~any ~~the~~of ~~case~~its current or former directors or officers.

~~Other~~On ~~than~~October ~~legal~~22, ~~fees~~2025, nothe ~~material~~parties ~~expense~~executed ~~related~~a toStipulation of Settlement in the ~~Protein~~California ~~Products~~State Case (the “Multistate Settlement”). The Multistate Settlement also encompasses the California Federal Class Lawsuit ~~was~~(which ~~incurred~~has ~~during~~been consolidated with the ~~three~~California orState ~~nine~~Case) ~~months~~and ~~ended~~the ~~June~~Related 30Federal Actions (which will be added to the California State Case via a stipulated amended complaint pursuant to the terms of the Multistate Settlement) excluding New York and New Mexico. On October 23, 2025, Plaintiffs filed an unopposed motion for preliminary approval of the Multistate Settlement. On January 8, 2026, the court granted preliminary approval of the Multistate Settlement and scheduled a final approval hearing for May 5, 2026. Pursuant to the terms of the New York Settlement, the Company will pay $2.0 into a settlement fund in the second quarter of fiscal 2026 to resolve the Multistate Case. Pursuant to the terms of the Multistate Settlement, if the settlement receives final approval and becomes effective, the Company will pay a total of $70.8 into a settlement fund to resolve the California State Case, California Federal Class Lawsuit, and Related Federal Actions excluding New York and New Mexico. The Multistate Settlement does not constitute an admission of liability or ~~2024~~wrongdoing by the Company or any of its current or former directors or officers.

~~California~~On ~~Proposition~~November 6512, ~~Notice~~2025, rethe ~~Lead~~parties entered into a confidential settlement agreement and release in ~~Protein~~the ~~Products~~New Mexico Federal Related Action, which is not subject to court approval. Pursuant to the terms of the settlement agreement, the Company made an immaterial payment to resolve the New Mexico action and plaintiff filed a notice of voluntary dismissal with prejudice on December 15, 2025.

OnOther ~~June~~than 7,legal ~~2023~~fees, ~~the~~no ~~Fitzgerald~~expense ~~Joseph~~related ~~LLP~~to ~~law~~this ~~firm~~litigation ~~(the~~was ~~same~~incurred ~~firm~~during ~~that filed~~ the ~~Protein~~three ~~Products~~months ~~Class~~ended ~~Lawsuit)~~December ~~issued~~31, a2025 ~~60-Day~~and ~~Notice~~2024, ofrespectively. ~~Intent~~At toDecember ~~Sue~~31, ~~under~~2025 ~~California’s Safe Water~~ and ~~Toxic~~September ~~Enforcement~~30, ~~Act~~2025, ~~(Proposition~~the ~~65)~~Company ~~for~~had ~~alleged~~an ~~violation~~estimated liability of ~~Proposition~~$88.0 65and ~~with~~$90.0, ~~respect~~respectively, related to ~~lead~~these ~~levels~~matters inthat ~~Premier~~was ~~Nutrition’s~~included ~~RTD~~in ~~protein~~“Other ~~shakes~~current ~~and~~liabilities” ~~protein~~on ~~powders (this matter is hereinafter referred to as~~ the ~~“Protein~~Condensed ~~Products~~Consolidated ~~Prop~~Balance ~~65 Notice”)~~Sheets.

~~Premier~~Putative ~~Nutrition~~Securities ~~intends~~Class toAction vigorously defend against the Protein Products Prop 65 Notice. The Company does not believe that the ultimate resolution of the Protein Products Prop 65 Notice will have a material adverse effect on its consolidated financial condition, results of operations or cash flows.Litigation

~~Other~~On ~~than~~January ~~legal~~22, ~~fees~~2026, noa ~~expense~~putative ~~related~~securities toclass ~~the~~action ~~Protein~~captioned ~~Products~~Denha ~~Prop~~v. 65BellRing ~~Notice~~Brands, Inc. was ~~incurred~~filed ~~during~~in the ~~three~~U.S. orDistrict ~~nine~~Court ~~months~~for ~~ended~~the ~~June~~Southern 30District of New York against the Company and Darcy Horn Davenport, ~~2025~~the orCompany’s ~~2024~~President and Chief Executive Officer, and Paul Rode, the Company’s Chief Financial Officer and Treasurer. The complaint

Other

The Company is subject to various other legal proceedings and actions arising in the normal course of business. In the opinion of management, based upon the information presently known, the ultimate liability, if any, arising from such pending legal proceedings, as well as from asserted legal claims and known potential legal claims which are likely to be asserted, taking into account established accruals for estimated liabilities (if any), are not expected to be material individually or in the aggregate to the consolidated financial condition, results of operations or cash flows of the Company. In addition, although it is difficult to estimate the potential financial impact of actions regarding expenditures for compliance with regulatory matters, in the opinion of management, based upon the information currently available, the ultimate liability arising from such compliance matters is not expected to be material to the consolidated financial condition, results of operations or cash flows of the Company.

Table of Contents

alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 based on alleged misstatements regarding the Company’s financial performance and prospects during the period from November 19, 2024 through August 4, 2025. The plaintiff seeks unspecified compensatory damages, attorneys’ fees and other relief as the court may deem appropriate. Motions for appointment of lead plaintiff and lead counsel are due by March 23, 2026. The Company intends to defend the action vigorously. Given the early stage of this litigation, the Company is unable to predict the outcome or estimate the amount of loss, if any, that may result from the litigation.

Other

NOTE 14 — STOCKHOLDERS’ DEFICIT

The following table summarizes the Company’s repurchases of its common stock.

	Three Months EndedJune 30,				Nine Months EndedJune 30,
			Three Months EndedDecember 31,
	~~2025~~		~~2024~~		2025		2024
Shares repurchased	~~1.3~~		~~1.3~~		3.80		10.91
Average price per share (a)	$	~~65.07~~	$	~~58.08~~	$	6931.6795	$	5677.1812
Total share repurchase cost (b)	$	~~83.9~~	$	~~74.6~~	$	~~267~~97.68	$	~~107~~11.10

(a)Average price per share excludes any accrued excise tax and broker’s commissions, which are included in “Total share repurchase cost” within this table.

(b)“Purchases of treasury stock” in the Condensed Consolidated Statements of Cash Flows for the ~~nine~~three months ended ~~June~~December 3031, 2025 excluded $10.9 of accrued excise tax that had not been paid as of ~~June~~December 3031, 2025 ~~and included $2~~.2 ~~of accrued excise tax payments that had been accrued in prior fiscal years.~~ “Purchases of treasury stock” in the Condensed Consolidated Statements of Cash Flows for the ~~nine~~three months ended ~~June~~December 3031, 2024 ~~excluded~~included $1.0.8 of ~~accrued~~ excise tax payments that had ~~not~~ been ~~paid~~accrued asin offiscal ~~June 30,~~ 2024.

NOTE 15 — SUBSEQUENT EVENT

On July 4, 2025, the H.R.1 tax law was enacted in the U.S. (the “H.R.1 Tax Act”). The H.R.1 Tax Act includes provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act of 2017, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The H.R.1 Tax Act has multiple effective dates, beginning in calendar year 2025 and extending through calendar year 2027. The Company is currently evaluating the impact of the H.R.1 Tax Act on its effective income tax rate, results of operations, financial condition and cash flows.

Table of Contents

NOTE 15 — SEGMENTS

The Company manages its operations on a consolidated basis through one operating and reportable segment. The Company’s Chief Operating Decision Maker (“CODM”) is the President and Chief Executive Officer of BellRing. The CODM utilizes consolidated single-segment net earnings (reported on the Condensed Consolidated Statements of Operations as “Net Earnings”) to evaluate financial performance, allocate resources and forecast future period financial results. The CODM evaluates performance by comparing actual to budgeted results and utilizes this information to decide whether to reinvest into the segment or into other parts of the entity, such as for acquisitions or to repurchase shares. The measure of segment assets is reported on the Condensed Consolidated Balance Sheets as “Total Assets”.

The following table presents net sales, the significant expense categories reviewed by the CODM and net earnings of the Company.


	Three Months Ended December 31,
	2025		2024
Net Sales	$	537.3	$	532.9
Less:
Cost of goods sold	376.5		333.3
Advertising expenses	12.4		15.1
Amortization of intangible assets	4.3		4.2
Other segment expenses (a)	65.6		65.0
Interest expense, net	20.0		14.4
Income tax expense	14.8		24.0
Net Earnings	$	43.7	$	76.9

(a)Other segment expenses includes employee-related expenses, marketing and distribution, research and development, outside professional services, depreciation and other general expenses.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion summarizes the significant factors affecting the consolidated operating results, financial condition, liquidity and capital resources of BellRing Brands, Inc. and its consolidated subsidiaries. This discussion should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto included herein, our audited consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended September 30, ~~2024~~2025 and the “Cautionary Statement on Forward-Looking Statements” section included below. The terms “our,” “we,” “us,” “Company” and “BellRing” refer to BellRing Brands, Inc. and its consolidated subsidiaries.

OVERVIEW

We are a consumer products holding company operating in the global ~~convenient~~proactive ~~nutrition~~wellness category and are a provider of ready-to-drink (“RTD”) protein shakes and powders. We have a single operating and reportable segment, with our principal products being protein-based consumer goods. Our primary brands are Premier Protein and Dymatize.

Market Trends

During fiscal ~~2024,~~2025 ~~inflationary~~and ~~pressures~~continuing oninto ~~protein~~fiscal ~~costs~~2026, ~~eased~~input ~~while other~~ costs, ~~such~~including asraw material, packaging and manufacturing costs, have faced inflationary pressures., ~~During~~including ~~fiscal~~from ~~2025,~~the ~~input~~impact ~~costs,~~of ~~including~~tariffs ~~raw~~beginning ~~material,~~in ~~packaging~~fiscal ~~and~~2026. ~~manufacturing~~In ~~costs~~addition, ~~have~~we ~~faced~~anticipate that announced tariffs, and ~~continue~~any topotential ~~face,~~future ~~inflationary~~modifications ~~pressures.~~or ~~Inflation~~incremental ~~(including~~tariffs, ~~the~~could ~~potential~~increase ~~impact~~supply ofchain ~~tariffs)~~challenges, ~~could~~commodity ~~have~~cost avolatility ~~materially~~and ~~adverse~~consumer ~~impact~~and oneconomic ~~our~~uncertainty ~~business~~due to rapid changes in ~~the~~global ~~future~~trade ifpolicies. ~~inflation~~We ~~rates~~expect ~~were~~these trends to ~~significantly~~have ~~exceed~~a ~~our~~materially ~~ability~~adverse toimpact ~~achieve~~on ~~price~~our ~~increases~~results orof ~~cost~~operations ~~savings~~if orwe ifare ~~such~~unable ~~price~~to ~~increases~~mitigate the impact ~~demand~~on ~~for~~ our ~~products~~business.

For additional discussion, refer to “Liquidity and Capital Resources” and “Cautionary Statement on Forward-Looking Statements” within this section.

RESULTS OF OPERATIONS

	Three Months Ended June 30,				Change in				Nine Months Ended June 30,				Change in
					Three Months Ended December 31,				Change in
dollars in millions	~~2025~~		~~2024~~		$		%		2025		2024		$		%
Net Sales	$	~~547.5~~	$	~~515.4~~	$	~~32.1~~	6	%	$	~~1,668~~537.43	$	~~1,440~~532.49	$	~~228~~4.04	161	%
Operating Profit	$	~~44.8~~	$	~~111.6~~	$	~~(66.8)~~	~~(60)~~	%	$	~~255~~78.25	$	~~275~~115.63	$	(2036.48)	(732)	%
Interest expense, net	~~18.4~~		~~14.4~~		~~4.0~~		28	%	4920.30		4314.84		5.56		1339	%
Income tax expense	~~5.4~~		~~23.5~~		~~(18.1)~~		~~(77)~~	%	4914.38		5724.0		(79.72)		(1438)	%
Net Earnings	$	~~21.0~~	$	~~73.7~~	$	~~(52.7)~~	~~(72)~~	%	$	~~156~~43.67	$	~~174~~76.89	$	(1833.2)	(1043)	%

Net Sales

Net sales increased $324.1 4 million, or 61%, during the three months ended ~~June~~December 3031, 2025 compared to the prior year period. Sales of Premier Protein products were updown $265.37 million, or 61%, ~~driven~~on byflat ~~3% higher~~ volumes, ~~primarily~~driven ~~due~~by tolower ~~distribution~~average ~~gains and incremental promotional activity. Average~~ net selling prices ~~increased~~ due to ~~targeted~~incremental ~~price increases, partially offset by increased~~ promotional ~~activity~~investment. Sales of Dymatize products were up $39.69 million, or 516%, driven by 530% higher volumes primarily due to higher international volumes. ~~and~~Average ~~new~~net selling prices decreased due to unfavorable product ~~introductions~~mix. Sales of all other products were up $20.2 million.

Net sales increased $228.0 million, or 16%, during the nine months ended June 30, 2025 compared to the prior year period. Sales of Premier Protein products were up $214.6 million, or 18%, driven by 13% higher volumes primarily due to distribution gains and incremental promotional activity. Average net selling prices increased due to targeted price increases, partially offset by incremental promotional activity. Sales of Dymatize products were up $12.5 million, or 7%, driven by 12% higher volumes primarily due to higher international volumes and new product introductions. Average net selling prices decreased due to unfavorable product mix. Sales of all other products were up $0.9 million.

Operating Profit

Operating profit decreased $6636.8 million, or 6032%, during the three months ended ~~June~~December 3031, 2025 compared to the prior year period. This decrease was primarily driven by ahigher ~~provision~~net ~~for~~product ~~legal~~costs ~~matters~~ of $6835.19 million ~~in the current year period~~ (asprimarily ~~discussed~~driven inby ~~Note~~higher 13raw ~~within~~material ~~“Notes~~and tomanufacturing ~~Condensed~~costs), ~~Consolidated~~partially ~~Financial~~offset ~~Statements”~~by ~~included~~reduced inadvertising ~~Part~~expenses ~~I, Item 1~~ of ~~this~~$2.7 ~~report)~~ million.

Table of Contents

and higher net product costs of $18.6 million (driven by higher raw material and manufacturing costs, partially offset by lower freight costs). These negative impacts were partially offset by higher net sales, as previously discussed.

Operating profit decreased $20.4 million, or 7%, during the nine months ended June 30, 2025 compared to the prior year period. This decrease was primarily driven by a provision for legal matters of $69.0 million in the current year period, higher net product costs of $33.9 million (driven by higher raw material and manufacturing costs, partially offset by lower freight costs), increased advertising expense of $22.8 million and higher warehousing and distribution costs of $9.5 million. These negative impacts were partially offset by higher net sales, as previously discussed, and accelerated amortization of $17.4 million recorded in the prior year period related to the discontinuance of the PowerBar business in North America.

Interest Expense, Net

Interest expense, net increased $45.06 million during the three months ended ~~June~~December 3031, 2025 compared to the prior year period primarily due to higher outstanding borrowings under our Revolving Credit Facility (as defined in “Liquidity and Capital Resources” below). The weighted-average interest rate on our total outstanding debt was 76.49% and 7.0% for the three months ended ~~June~~December 3031, 2025 and 2024, respectively. See Note 12 within “Notes to Condensed Consolidated Financial Statements” for additional information on our debt.

Interest expense, net increased $5.5 million during the nine months ended June 30, 2025 compared to the prior year period primarily due to higher outstanding borrowings under our Revolving Credit Facility. The weighted-average interest rate on our total outstanding debt was 7.2% and 7.0% for the nine months ended June 30, 2025 and 2024, respectively. See Note 12 within “Notes to Condensed Consolidated Financial Statements” for additional information on our debt.

Income Tax Expense

Our effective income tax rate was 20.5% and 24.2% for the three months ended June 30, 2025 and 2024, respectively, and 23.9% and 24.6% for the nine months ended June 30, 2025 and 2024, respectively. The decrease in our effective income tax rate during the three months ended June 30, 2025 compared to the prior year period was primarily due to discrete tax benefits recognized in the current year period related to prior year tax accruals.

On July 4, 2025, subsequent to the end of the period covered by this report, the H.R.1 tax law was enacted in the United States (the “H.R.1 Tax Act”). The H.R.1 Tax Act includes provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act of 2017, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The H.R.1 Tax Act has multiple effective dates, beginning in calendar year 2025 and extending through calendar year 2027. We are currently evaluating the impact of the H.R.1 Tax Act on our effective income tax rate, results of operations, financial condition and cash flows.

LIQUIDITY AND CAPITAL RESOURCES

During the nine months ended June 30, 2025, we borrowed $360.0 million and repaid $185.0 million under our revolving credit facility, which is provided under our credit agreement entered into on March 10, 2022 (as amended, the “Credit Agreement”) in an aggregate principal amount of $250.0 million (the “Revolving Credit Facility”). As of June 30, 2025, we had $75.0 million of available borrowing capacity and no letters of credit outstanding under the Revolving Credit Facility. Letters of credit are available under the Revolving Credit Facility in an aggregate amount of up to $20.0 million. Our Credit Agreement provides for potential incremental revolving and term facilities at the Company’s request and at the discretion of the lenders or other persons providing such incremental facilities, in each case on terms to be determined, and also permits the Company to incur other secured or unsecured debt, in all cases subject to conditions and limitations as specified in the Credit Agreement.

During the nine months ended June 30, 2025, we repurchased 3.8 million shares of our common stock at an average share price of $69.67 per share and at a total cost, including any accrued excise tax and broker’s commissions, of $267.6 million. In addition, during the nine months ended June 30, 2025, we paid $2.2 million of excise tax that related to fiscal 2024 and 2023 share repurchases.

We expect to generate positive cash flows from operations and believe our cash on hand, cash flows from operations and possible future credit facilities will be sufficient to satisfy our future working capital requirements, purchase commitments, research and development activities, debt repayments (including interest payments), share repurchases and other financing requirements for the foreseeable future. We are currently not aware of any trends or demands, commitments, events or uncertainties that will result in, or that are reasonably likely to result in, our liquidity increasing or decreasing in any material way that will impact meeting our capital needs during or beyond the next twelve months. Our ability to generate positive cash flows from operations is dependent on general economic conditions, competitive pressures and other business risk factors. We believe that we have sufficient liquidity and cash on hand to satisfy our cash needs. If we are unable to generate sufficient cash flows from operations, or otherwise to comply with the terms of our credit facilities, we may be required to seek additional financing alternatives.

Table of Contents

~~Short-term~~Income ~~financing~~Tax needs primarily consist of working capital requirements, interest payments on our 7.00% senior notes maturing in March 2030 (the “7.00% Senior Notes”) and on outstanding borrowings under our Revolving Credit Facility and our provision for legal matters. Long-term financing needs include the repayment of our 7.00% Senior Notes and outstanding borrowings under our Revolving Credit Facility. Additional long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and other strategic transactions. Our asset-light business model requires modest capital expenditures, with annual capital expenditures over the last three fiscal years averaging less than 1% of net sales. No significant capital expenditures are planned during the next 12 months. Additionally, we may seek to repurchase shares of our common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.Expense

Our effective income tax rate was 25.3% and 23.8% for the three months ended December 31, 2025 and 2024, respectively.

LIQUIDITY AND CAPITAL RESOURCES

During the three months ended December 31, 2025, we borrowed $180.0 million and repaid $80.0 million under our revolving credit facility (the “Revolving Credit Facility”) provided for under our amended credit agreement (the “Credit Agreement”). As of December 31, 2025, we had $147.6 million of available borrowing capacity, including $2.4 million letters of credit outstanding under the Revolving Credit Facility. Letters of credit are available under the Revolving Credit Facility in an aggregate amount of up to $20.0 million. Our Credit Agreement provides for potential incremental revolving and term facilities at the Company’s request and at the discretion of the lenders or other persons providing such incremental facilities, in each case on terms to be determined, and also permits the Company to incur other secured or unsecured debt, in all cases subject to conditions and limitations as specified in the Credit Agreement.

During the three months ended December 31, 2025, we repurchased 3.0 million shares of our common stock at an average share price of $31.95 per share and at a total cost, including any accrued excise tax and broker’s commissions, of $97.8 million.

We expect to generate positive cash flows from operations over the next twelve months and believe our cash on hand, cash flows from operations and possible future credit facilities will be sufficient to satisfy our future working capital requirements, purchase commitments, research and development activities, debt repayments (including interest payments), share repurchases and other financing requirements for the foreseeable future. We are currently not aware of any trends or demands, commitments, events or uncertainties that will result in, or that are reasonably likely to result in, our liquidity increasing or decreasing in any material way that will impact meeting our capital needs during or beyond the next twelve months. Our ability to generate positive cash flows from operations is dependent on general economic conditions, competitive pressures and other business risk factors. We believe that we have sufficient liquidity and cash on hand to satisfy our cash needs. If we are unable to generate sufficient cash flows from operations, or otherwise to comply with the terms of our credit facilities, we may be required to seek additional financing alternatives.

Short-term financing needs primarily consist of working capital requirements, interest payments on our 7.00% senior notes maturing in March 2030 (the “7.00% Senior Notes”) and on outstanding borrowings under our Revolving Credit Facility and payments on our provision for legal matters. Long-term financing needs include the repayment of our 7.00% Senior Notes and outstanding borrowings under our Revolving Credit Facility. Additional long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and other strategic transactions. Our asset-light business model requires modest capital expenditures, with annual capital expenditures over the last three fiscal years averaging less than 1% of net sales. No significant capital expenditures are planned during the next 12 months. Additionally, we may seek to repurchase shares of our common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.

The following table presents select cash flow data, which is discussed below.

	Nine Months EndedJune 30,
	Three Months EndedDecember 31,
dollars in millions	2025		2024
Cash provided by (used in):
Cash (used in) provided by:
Operating activities	$	91(3.51)	$	~~159~~3.50
Investing activities	(34.72)		(01.63)
Financing activities	(~~104~~5.43)		(~~134~~23.62)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0.45		~~(0.1)~~—
Net (decrease) increase in cash, cash equivalents and restricted cash	$	(16.2)	$	24.2
Net decrease in cash, cash equivalents and restricted cash	$	(12.1)	$	(21.5)

Operating Activities

Cash ~~provided~~used byin operating activities for the ~~nine~~three months ended ~~June~~December 3031, 2025 ~~decreased~~was $683.01 million compared to cash provided by operating activities of $3.0 million for the ~~prior~~three ~~year~~months ~~period~~ended December 31, 2024. This decrease was primarily due to increased inventory levels in the current year period (driven by higher production), ~~increased~~fluctuations ~~tax~~in ~~payments~~the ~~(net~~timing of ~~refunds)~~collections of ~~$9.9~~trade ~~million~~receivables and increased interest payments of $43.9 million,. These impacts were partially offset by fluctuations in the timing of ~~collections~~payments of trade ~~receivables~~payables and decreased tax payments (net of refunds) of $20.5 million.

Table of Contents

Investing Activities

Cash used in investing activities for the ~~nine~~three months ended ~~June~~December 3031, 2025 increased $32.19 million compared to the prior year period ~~resulting~~driven ~~from~~by an increase in capital expenditures.

Financing Activities

Cash used in financing activities for the ~~nine~~three months ended ~~June~~December 3031, 2025 decreased $3017.29 million compared to the prior year period, driven by higher ~~payments~~borrowings of $~~161~~145.~~8 million, including excise tax payments and broker’s commissions, for the repurchase of our common stock, higher repayments of $160.~~0 million under ~~the~~our Revolving Credit Facility and ~~higher~~lower tax withholding payments related to stock compensation plans of $83.0 million. These cash ~~outflows~~inflows were partially offset by higher ~~borrowings~~payments of $~~360~~85.1 million, including broker’s commissions, for the repurchase of our common stock and higher repayments of $45.0 million under ~~the~~our Revolving Credit Facility.

Debt Covenants

The Credit Agreement contains affirmative and negative covenants applicable to us and our restricted subsidiaries customary for agreements of this type, including delivery of financial and other information; compliance with laws; maintenance of property, existence, insurance and books and records; providing inspection rights; obligation to provide collateral and guarantees by certain new subsidiaries; delivery of environmental reports; participation in an annual meeting with the agent and the lenders; further assurances; and limitations with respect to indebtedness, liens, fundamental changes, restrictive agreements, use of proceeds, amendments of organization documents, prepayments and amendments of certain indebtedness, dispositions of assets, acquisitions and other investments, sale leaseback transactions, changes in the nature of business, transactions with affiliates and dividends and redemptions or repurchases of stock. Under the terms of the Credit Agreement, we are also required to comply with a financial covenant requiring us to maintain a total net leverage ratio (as defined in the Credit Agreement) not to exceed 6.00:1.00, measured as of the last day of each fiscal quarter. We were in compliance with the financial covenant as of ~~June~~December 3031, 2025, and we do not believe non-compliance is reasonably likely in the foreseeable future.

The Credit Agreement provides for potential incremental revolving and term facilities at our request and at the discretion of the lenders or other persons providing such incremental facilities, in each case on terms to be determined, and also permits us to incur other secured or unsecured debt, in all cases subject to conditions and limitations as specified in the Credit Agreement.

Table of Contents

In addition, the indenture governing the 7.00% Senior Notes contains negative covenants customary for this type of agreement that limit our ability and the ability of our restricted subsidiaries to, among other things: borrow money or guarantee debt; create liens; pay dividends on, or redeem or repurchase, stock; make specified types of investments and acquisitions; enter into or permit to exist contractual limits on the ability of our subsidiaries to pay dividends to us; enter into transactions with affiliates; and sell assets or merge with other companies. Certain of these covenants are subject to suspension when and if the 7.00% Senior Notes receive investment grade ratings.

CRITICAL ACCOUNTING ESTIMATES

Our critical accounting estimates are more fully described in our Annual Report on Form 10-K for the year ended September 30, ~~2024~~2025, as filed with the Securities and Exchange Commission (the “SEC”) on November 1918, ~~2024~~2025. There have been no significant changes to our critical accounting estimates since September 30, ~~2024~~2025.

RECENTLY ISSUED ACCOUNTING STANDARDS

See Note 2 within “Notes to Condensed Consolidated Financial Statements” for a discussion regarding recently issued accounting standards.

CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

Forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act, are made throughout this report, including statements regarding unanticipated developments that negatively impact our common stock. These forward-looking statements are sometimes identified from the use of forward-looking words such as “believe,” “should,” “could,” “potential,” “continue,” “expect,” “project,” “estimate,” “predict,” “anticipate,” “aim,” “intend,” “plan,” “forecast,” “target,” “is likely,” “will,” “can,” “may” or “would” or the negative of these terms or similar expressions elsewhere in this report. Our financial condition, results of operations and cash flows may differ materially from those in the forward-looking statements. Such statements are based on management’s current views and assumptions and involve risks and uncertainties that could affect expected results. Those risks and uncertainties include, but are not limited to, the following:

•our dependence on sales from our RTD protein shakes;

Table of Contents

•our ability to continue to compete in our product categories and our ability to retain our market position and favorable perceptions of our brands;

•disruptions or inefficiencies in our supply chain, including as a result of our reliance on third-party suppliers or manufacturers for the manufacturing of many of our products, pandemics and other outbreaks of contagious diseases, labor shortages, fires and evacuations related thereto, changes in weather conditions, natural disasters, agricultural diseases and pests and other events beyond our control;

•our dependence on third-party contract manufacturers for the manufacture of most of our products, including one manufacturer for nearly half of our RTD protein shakes;

•the ability of our third-party contract manufacturers to produce an amount of our products that enables us to meet customer and consumer demand for the products;

•our reliance on a limited number of third-party suppliers to provide certain ingredients and packaging;

•significant volatility in the cost or availability of inputs to our business (including freight, raw materials, packaging, energy, labor and other supplies), including as a result of tariffs or inflationary pressures;

•our ability to anticipate and respond to changes in consumer and customer preferences and behaviors and introduce new products;

•consolidation in our distribution channels;

•our ability to expand existing market penetration and enter into new markets;

•the loss of, a significant reduction of purchases by or the bankruptcy of a major customer;

•legal and regulatory factors, such as compliance with existing laws and regulations, as well as new laws and regulations and changes to existing laws and regulations and interpretations thereof, affecting our business, including current and future laws and regulations regarding food safety, advertising, labeling, tax matters and environmental matters;

•fluctuations in our business due to changes in our promotional activities and seasonality;

Table of Contents

•our ability to maintain the net selling prices of our products and manage promotional activities with respect to our products;

•our ability to obtain additional financing (including both secured and unsecured debt) and our ability to service our outstanding debt (including covenants that restrict the operation of our business);

•the accuracy of our market data and attributes and related information;

•changes in critical accounting estimates;

•uncertain or unfavorable economic conditions that limit customer and consumer demand for our products or increase our costs;

•risks related to our ongoing relationship with Post Holdings, Inc. (“Post”) following our separation from Post and Post’s distribution of our stock to its shareholders (the “Spin-off”), including our obligations under various agreements with Post;

•conflicting interests or the appearance of conflicting interests resulting from certain of our directors also serving as officers and/or directors of Post;

•risks related to the previously completed Spin-off;

•the ultimate impact litigation or other regulatory matters may have on us;

•risks associated with our international business;

•our ability to protect our intellectual property and other assets and to continue to use third-party intellectual property subject to intellectual property licenses;

•costs, business disruptions and reputational damage associated with technology failures, cybersecurity incidents and corruption of our data privacy protections;

•impairment in the carrying value of goodwill or other intangible assets or other long-lived assets;

•our ability to identify, complete and integrate or otherwise effectively execute acquisitions or other strategic transactions and effectively manage our growth;

Table of Contents

•our ability to hire and retain talented personnel, employee absenteeism, labor strikes, work stoppages or unionization efforts;

•our ability to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002;

•significant differences in our actual operating results from any guidance we may give regarding our performance; and

•other risks and uncertainties included under “Risk Factors” in this report and in our Annual Report on Form 10-K for the fiscal year ended September 30, ~~2024~~2025, filed with the SEC on November 1918, ~~2024~~2025.

You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this report to conform these statements to actual results or to changes in our expectations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Commodity Price Risk

In the ordinary course of business, the Company is exposed to commodity price risks relating to the purchases of raw materials. The Company may use futures contracts and options to manage certain of these exposures when it is practical to do so. A hypothetical 10% adverse change in the underlying market ~~price~~prices of the Company’s principal hedged ~~commodities,~~commodity (non-fat dry milk), reflecting the sensitivity of the Company’s outstanding derivative positions to changes in commodity prices, would have ~~decreased~~changed the fair value of the Company’s commodity-related derivatives portfolio by ~~less~~approximately ~~than~~$9 million and $112 million as of ~~both~~December ~~June 30~~31, 2025 and September 30, ~~2024~~2025, respectively. This volatility analysis ignores changes in the exposures inherent in the underlying hedged transactions. Because the Company does not hold or trade derivatives for speculation or profit, all changes in derivative values are effectively offset by corresponding changes in the underlying commodity exposures.

For additional information regarding the Company’s commodity contracts, see Note 10 within “Notes to Condensed Consolidated Financial Statements.”

Table of Contents

Foreign Currency Risk

Related to Active Nutrition International GmbH, whose functional currency is the Euro, the Company is exposed to risks of fluctuations in future cash flows and earnings due to changes in foreign currency exchange rates. Related to Premier Nutrition Company, LLC, a subsidiary of the Company whose functional currency is the U.S. Dollar, the Company is exposed to foreign currency transactional risk as it sells to certain customers in Canadian dollars (“CAD”). The foreign currency balance sheet exposures as a result of these CAD transactions are not expected to result in a significant impact on future earnings or cash flows.

Interest Rate Risk

As of both ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the Company had outstanding principal value indebtedness of $840.0 million related to its 7.00% Senior Notes. Additionally, the Company had outstanding borrowings of $~~175~~350.0 million and $250.0 million under its Revolving Credit Facility as of ~~June~~December 3031, 2025 and ~~no amounts outstanding under its Revolving Credit Facility as of~~ September 30, ~~2024~~2025, respectively. Borrowings under the Revolving Credit Facility had a variable interest rate of 95.5078% and 6.14% as of ~~June~~December 31, 2025 and September 30, 2025, respectively.

As of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, the fair value of the Company’s debt, excluding any borrowings under its Revolving Credit Facility, was $~~876~~869.2 million and $~~880~~869.60 million, respectively. Changes in interest rates impact fixed and variable rate debt differently. For fixed rate debt, a change in interest rates will only impact the fair value of the debt, whereas a change in interest rates on variable rate debt will impact interest expense and cash flows. A hypothetical 10% decrease in interest rates would have ~~increased~~changed the fair value of the fixed rate debt by approximately $6 4 million and $7 5 million as of ~~June~~December 3031, 2025 and September 30, ~~2024~~2025, respectively. A hypothetical 10% increase in interest rates would have had an immaterial impact on both interest expense and interest paid during the three ~~and nine~~ months ended ~~June~~December 3031, 2025, and ~~the Company had no variable rate debt outstanding as of September 30~~2024, ~~2024~~respectively. For additional information regarding the Company’s debt, see Note 12 within “Notes to Condensed Consolidated Financial Statements.”

Table of Contents

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Management, with the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) of the Company, has evaluated the effectiveness of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, the CEO and CFO concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were effective to provide reasonable assurance of achieving the desired control objectives.

Changes in Internal Control Over Financial Reporting

There were no significant changes in the Company’s internal control over financial reporting during the quarter ended ~~June~~December 3031, 2025 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

1920

Table of Contents

PART II. OTHER INFORMATION.

ITEM 1. LEGAL PROCEEDINGS.

The information required under this Item 1 is set forth in Note 13 within “Notes to Condensed Consolidated Financial Statements” included in Part I, Item 1 of this report, which is incorporated herein by reference. For disclosure of environmental proceedings with a governmental entity as a party pursuant to Item 103(c)(3)(iii) of Regulation S-K, the Company has elected to disclose matters where the Company reasonably believes such proceeding would result in monetary sanctions, exclusive of interest and costs, of $1.0 million or more. Applying this threshold, there are no such environmental proceedings to disclose for the three months ended ~~June~~December 3031, 2025.

ITEM 1A. RISK FACTORS.

In addition to the information set forth elsewhere in this Quarterly Report on Form 10-Q (the “Quarterly Report”), you should carefully consider the risk factors we previously disclosed in our Annual Report on Form 10-K, filed with the SEC on November 1918, ~~2024~~2025, as of and for the year ended September 30, ~~2024~~2025 (the “Annual Report”). As of the date of this Quarterly Report, there have been no material changes to the risk factors previously disclosed in the Annual Report. These risks could materially and adversely affect our business, financial condition, results of operations and cash flows. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business, financial condition, results of operations and cash flows.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

The following table sets forth information with respect to repurchases of shares of our common stock during the three months ended ~~June~~December 3031, 2025 and our common stock repurchase authorization.

Period	Total Number of Shares Purchased	Average Price Paid per Share (a)	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (b)	Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs (b)
April 1, 2025 - April 30, 2025	270,142	$72.91	270,142	$260,305,135
October 1, 2025 - October 31, 2025	1,176,132	$34.01	1,176,132	$276,502,949
May 1, 2025 - May 31, 2025	759,578	$62.99	759,578	$212,456,712
November 1, 2025 - November 30, 2025	1,405,668	$30.56	1,405,668	$557,048,367
June 1, 2025 - June 30, 2025	245,226	$62.87	245,226	$197,039,286
December 1, 2025 - December 31, 2025	450,773	$30.94	450,773	$543,099,452
Total	13,~~274~~032,~~946~~573	$6531.0795	13,~~274~~032,~~946~~573	$~~197~~543,~~039~~099,~~286~~452

(a)Does not include broker’s commissions or accrued excise tax, if any.

(b)On ~~March~~September 62, 2025, the Company’s Board of Directors approved a $400,000,000 repurchase authorization with respect to shares of the Company’s common stock (the “Prior Authorization”). The Prior Authorization was effective on September 2, 2025 and had an expiration date of September 2, 2027. On November 19, 2025, the Company’s Board of Directors approved a new $~~300~~600,000,000 repurchase authorization with respect to shares of the Company’s common stock (the “New Authorization”) and cancelled, effective November 19, 2025, the Prior Authorization. The New Authorization was effective on ~~March~~November 619, 2025 and has an expiration date of ~~March~~November 619, 2027. Repurchases may be made from time to time in the open market, private purchases, through forward, derivative, accelerated repurchase or automatic purchase transactions, or otherwise.

Table of Contents

ITEM 5. OTHER INFORMATION.

Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements

During the three months ended ~~June~~December 3031, 2025, our directors or officers, as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended, adopted or terminated the “Rule 10b5-1 trading arrangements” as defined in Item 408 of Regulation S-K, set forth in the table below:

Type of Trading Arrangement

Name and Position

Date

Action

Rule 10b5-1*

Duration of Plan

Total Shares of Common Stock to be Sold

Douglas CornilleChief Growth Officer

6/3/2025

Terminate

12/6/2024 to 12/6/2025

Up to 12,769

Darcy H. DavenportPresident and Chief Executive Officer

12/5/2025

Adopt

12/5/2025 to 3/1/2027

Up to 45,616

Douglas CornilleChief Growth Officer

6/4/2025

Adopt

6/4/2025 to 6/4/2026

Up to 15,880

Craig L. RosenthalChief Legal Officer and Chief Compliance Officer

6/7/2025

Adopt

6/7/2025 to 6/7/2026

Up to 13,273

* Contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

Table of Contents

Leadership Transition

On February 2, 2026, Darcy H. Davenport, President and Chief Executive Officer of BellRing Brands, Inc. (the “Company”), advised the Company’s Board of Directors (the “Board”) of her retirement as President and Chief Executive Officer of the Company upon the earlier of the appointment of her successor or the end of the Company’s 2026 fiscal year (the “Transition Date”). The Company has begun a comprehensive external search process for Ms. Davenport’s successor. Any final succession decision will be determined at a future date and publicly announced.

Ms. Davenport and the Company have entered into a Transition and Advisory Agreement (the “Agreement”), effective February 3, 2026. Pursuant to the Agreement, Ms. Davenport has agreed to be employed by the Company as an advisor beginning on the Transition Date and through the end of calendar year 2028 (the “Advisory Term”). During the Advisory Term, Ms. Davenport will assist with the transition of her duties and provide strategic advice and support to the Board and senior management of the Company.

As compensation during the Advisory Term, Ms. Davenport will receive a base salary of $750,000 per year and be eligible to receive an annual bonus in a target amount of 100% of her base salary. In addition, Ms. Davenport will receive a grant of restricted stock units under the Company’s Amended 2019 Long-Term Incentive Plan with a grant date value of $3,500,000 (the “Transition Award”). The restricted stock units will vest 50% on each of the first and second anniversaries of the grant date, subject to Ms. Davenport’s continued employment. Under the Agreement, if Ms. Davenport’s employment as an Advisor is terminated by the Company without Cause or by Ms. Davenport for Good Reason (each as defined in the Agreement), Ms. Davenport will receive severance consisting of (i) a lump sum payment equal to the base salary payable through the end of the Advisory Term, (ii) a lump sum equal to the bonus that would have been paid to Ms. Davenport had she remained employed through the end of the Advisory Term, (iii) accelerated vesting of the Transition Award, (iv) with respect to any outstanding and unvested performance restricted stock units awards, vesting in such awards at the end of the performance period based on the Company’s achievement of the relevant performance targets and (v) a lump sum cash amount equal to the full cost of Ms. Davenport’s COBRA coverage until the end of the Advisory Term. Ms. Davenport must execute and not revoke a release of claims in favor of the Company to receive the foregoing severance benefits.

The foregoing description of the Agreement is not complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which is attached as Exhibit 10.27 to this report and incorporated by reference herein.

Table of Contents

ITEM 6. EXHIBITS.

The following exhibits are either provided with this Form 10-Q or are incorporated herein by reference.

Exhibit No.						Description
*2.1						Transaction Agreement and Plan of Merger, dated as of October 26, 2021, by and among Post Holdings, Inc., BellRing Brands, Inc., BellRing Distribution, LLC and BellRing Merger Sub Corporation (Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed on October 27, 2021)
2.2						Amendment No. 1 to Transaction Agreement and Plan of Merger, dated as of February 28, 2022, by and among Post Holdings, Inc., BellRing Brands, Inc., BellRing Distribution, LLC and BellRing Merger Sub Corporation (Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed on February 28, 2022)
3.1						BellRing Brands, Inc. Restated Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on January 31, 2025)
3.2						BellRing Brands, Inc. amended and restated Bylaws (Incorporated by reference to Exhibit 3.2 to the Company’s Form 8-K filed on January 31, 2025)
*4.1						Indenture, dated March 10, 2022, by and among BellRing Brands, Inc. and Computershare Trust Company, N.A., as trustee (Incorporated by reference to Exhibit 4.1 to the Company’s Second Form 8-K filed on March 10, 2022)
4.2						Form of Note (Incorporated by reference to Exhibit 4.2 to the Company’s Second Form 8-K filed on March 10, 2022, which Exhibit 4.2 is referenced in Exhibit 4.1 to such filing)
31.1						Certification of Darcy H. Davenport pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated August 5, 2025
*10.25						Stipulation of Settlement dated October 17, 2025 between Premier Nutrition Company, LLC and Mary Beth Montera, individually and on behalf of all others similarly situated
31.2						Certification of Paul A. Rode pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated August 5, 2025
*10.26						Stipulation of Settlement dated October 22, 2025 between Premier Nutrition Company, LLC and each of Patricia Bland, Edward White and Kathleen Sonner, individually and on behalf of all others similarly situated
32.1						Certification of Darcy H. Davenport and Paul A. Rode, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated August 5, 2025
†*10.27						Transition and Advisory Agreement dated February 3, 2026 between BellRing Brands, Inc. and Darcy H. Davenport
101						Interactive Data File (Form 10-Q for the quarterly period ended June 30, 2025 filed in iXBRL (Inline eXtensible Business Reporting Language)). The financial information contained in the iXBRL-related documents is “unaudited” and “unreviewed.”
31.1						Certification of Darcy H. Davenport pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated February 3, 2026
104						The cover page from the Company’s Form 10-Q for the quarterly period ended June 30, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language) and contained in Exhibit 101
31.2						Certification of Paul A. Rode pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated February 3, 2026
32.1						Certification of Darcy H. Davenport and Paul A. Rode, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated February 3, 2026
101						Interactive Data File (Form 10-Q for the quarterly period ended December 31, 2025 filed in iXBRL (Inline eXtensible Business Reporting Language)). The financial information contained in the iXBRL-related documents is “unaudited” and “unreviewed.”
104						The cover page from the Company’s Form 10-Q for the quarterly period ended December 31, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language) and contained in Exhibit 101

* Exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally to the Securities and Exchange Commission (the “SEC”) a copy of any omitted exhibit or schedule upon request by the SEC.


*			Exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally to the Securities and Exchange Commission (the “SEC”) a copy of any omitted exhibit or schedule upon request by the SEC.
†			These exhibits constitute management contracts, compensatory plans and arrangements.

Certain agreements and other documents filed as exhibits to this Quarterly Report on Form 10-Q contain representations and warranties that the parties thereto made to each other. These representations and warranties have been made solely for the benefit of the other parties to such agreements and may have been qualified by certain information that has been disclosed to the other parties to such agreements and other documents and that may not be reflected in such agreements and other documents. In addition, these representations and warranties may be intended as a way of allocating risks among parties if the statements contained therein prove to be incorrect, rather than as actual statements of fact. Accordingly, there can be no reliance on any such representations and warranties as characterizations of the actual state of facts. Moreover, information concerning the subject matter of any such representations and warranties may have changed since the date of such agreements and other documents.

2223

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, BellRing Brands, Inc. has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		BELLRING BRANDS, INC.
Date:	~~August~~February 53, ~~2025~~2026	By:	/s/ Paul A. Rode
			Paul A. Rode
			Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)

2324

Filing Compare · BELLRING BRANDS, INC.